Frost N, Bleckmann A, Griesinger F, Grohe C, et al. Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin
and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative,
Metastatic Lung Adenocarcinoma (AIO-TRK-0122). Clin Lung Cancer 2023;24:568-572.
PMID: 37169628